COVID antiviral drugs shown to be effective, especially for older persons--new study

Real-world study shows strong performance of COVID antivirals Focal Foto / Flickr cc CIDRAP

A new real-world study in Greece finds that for high-risk patients, COVID-19 antivirals are highly effective in reducing the risk of both hospitalization and death. The study is published in The Journal of Infectious Diseases.

Patients who were older than 75, and reported good drug adherence benefitted the most from the drugs molnupiravir (Lagevrio) and nirmatrelvir/ritonavir (Paxlovid)